Jones Financial Companies
ACAD icon

Jones Financial Companies’s Acadia Pharmaceuticals ACAD Stock Holding History

Jones Financial Companies’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87M Buy
113,289
+36,387
+47% +$801K ﹤0.01% 1431
2026
Q1 		$1.6M Buy
76,902
+75,625
+5,922% +$1.81M ﹤0.01% 1525
2025
Q4 		$34.1K Buy
1,277
+495
+63% +$11.8K ﹤0.01% 2703
2025
Q3 		$16.5K Buy
782
+100
+15% +$2.37K ﹤0.01% 2889
2025
Q2 		$15.1K Buy
682
+322
+89% +$5.99K ﹤0.01% 2715
2025
Q1 		$6.14K Buy
360
+198
+122% +$3.6K ﹤0.01% 2888
2024
Q4 		$2.97K Hold
162
– – ﹤0.01% 2906
2024
Q3 		$2.54K Buy
+162
New +$2.7K ﹤0.01% 2615

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jones Financial Companies's ACAD Position: Q2 2026 in Review

Jones Financial Companies increased its Acadia Pharmaceuticals (ACAD) stake by 47% in Q2 2026, buying an estimated $801K and bringing the position to 113,289 shares worth $2.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1431.

Jones Financial Companies first reported a position in ACAD in Q3 2024 and has held it in 8 quarters since. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Jones Financial Companies held 113,289 shares of Acadia Pharmaceuticals worth $2.87M as of Q2 2026.
  • Jones Financial Companies bought 36,387 Acadia Pharmaceuticals shares in Q2 2026, an estimated $801K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1431 holding.
  • Jones Financial Companies first reported a position in Acadia Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.